← FDA Drug Approvals (Drugs@FDA)

XATMEP

NDA · New Drug Application · Sponsor: AZURITY · Approved 2017-04-25

Drug application

FDA Application #

NDA208400

Application type

New Drug Application

Brand name

XATMEP

Generic name

METHOTREXATE

Active ingredients

METHOTREXATE SODIUM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

2017-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown